Abstract
Whey is a natural by-product of cheese making process. Bovine milk has about 3.5 % protein, 80 % of which are caseins and the remaining 20 % are whey proteins. Whey proteins contain all the essential amino acids and have the highest protein quality rating among other proteins. Advances in processing technologies have led to the industrial production of different products with varying protein contents from liquid whey. These products have different biological activities and functional properties. Also recent advances in processing technologies have expanded the commercial use of whey proteins and their products. As a result, whey proteins are used as common ingredients in various products including infant formulas, specialized enteral and clinical protein supplements, sports nutrition products, products specific to weight management and mood control. This brief review intends to focus on scientific evidence and recent findings related to the therapeutic potential of whey proteins and peptides.
Keywords: bioactive peptide, lactoferrin, immunoglobulin, β-lactoglobulin, α-lactalbumin, Whey proteins
Current Pharmaceutical Design
Title: Emerging Therapeutic Potential of Whey Proteins and Peptides
Volume: 12 Issue: 13
Author(s): A. S. Yalcin
Affiliation:
Keywords: bioactive peptide, lactoferrin, immunoglobulin, β-lactoglobulin, α-lactalbumin, Whey proteins
Abstract: Whey is a natural by-product of cheese making process. Bovine milk has about 3.5 % protein, 80 % of which are caseins and the remaining 20 % are whey proteins. Whey proteins contain all the essential amino acids and have the highest protein quality rating among other proteins. Advances in processing technologies have led to the industrial production of different products with varying protein contents from liquid whey. These products have different biological activities and functional properties. Also recent advances in processing technologies have expanded the commercial use of whey proteins and their products. As a result, whey proteins are used as common ingredients in various products including infant formulas, specialized enteral and clinical protein supplements, sports nutrition products, products specific to weight management and mood control. This brief review intends to focus on scientific evidence and recent findings related to the therapeutic potential of whey proteins and peptides.
Export Options
About this article
Cite this article as:
Yalcin S. A., Emerging Therapeutic Potential of Whey Proteins and Peptides, Current Pharmaceutical Design 2006; 12 (13) . https://dx.doi.org/10.2174/138161206776843296
DOI https://dx.doi.org/10.2174/138161206776843296 |
Print ISSN 1381-6128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4286 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
PET and SPECT Imaging for the Acceleration of Anti-Cancer Drug Development
Current Drug Targets The Anticancer Properties of Dietary Polyphenols and its Relation with Apoptosis
Current Pharmaceutical Design Indoleamine 2,3-Dioxygenase, an Emerging Target for Anti-Cancer Therapy
Current Cancer Drug Targets Emerging Role of Cetuximab in the Treatment of Colorectal Cancer
Recent Patents on Anti-Cancer Drug Discovery Targeting the Ubiquitin-Proteasome Pathway: An Emerging Concept in Cancer Therapy
Current Topics in Medicinal Chemistry Targeting Blood Vessels for the Treatment of Non-Small Cell Lung Cancer
Current Cancer Drug Targets Preclinical Models to Study Breast Cancer
Clinical Cancer Drugs Genetic Instability Influences Drug Response in Cancer Cells
Current Drug Targets Will Antiangiogenic Agents be a Future for Mesothelioma Therapy?
Current Medicinal Chemistry Lactate Transporters and pH Regulation: Potential Therapeutic Targets in Glioblastomas
Current Cancer Drug Targets Inhibitors of Cancer Stem Cells
Anti-Cancer Agents in Medicinal Chemistry Role of PPAR in Cardiovascular Diseases
Recent Patents on Cardiovascular Drug Discovery Pharmacometrics of Stilbenes: Seguing Towards the Clinic
Current Clinical Pharmacology Recent Advances in the Development of “Curcumin Inspired” Compounds as New Therapeutic Agents
Mini-Reviews in Medicinal Chemistry Angiogenesis Inhibitors and Radiation in Multimodality Cancer Therapy: Preclinical and Clinical Studies
Current Angiogenesis (Discontinued) Epigenetic Variation and Customising Nutritional Intervention
Current Pharmacogenomics and Personalized Medicine Prophylaxis of Cancer
Current Cancer Therapy Reviews Nucleosides, a Valuable Chemical Marker for Quality Control in Traditional Chinese Medicine Cordyceps
Recent Patents on Biotechnology Enteric Coated Guar Gum Microspheres of Ornidazole for Colonic Delivery
Current Nanoscience Oncogenic MicroRNA-27a is a Target for Genistein in Ovarian Cancer Cells
Anti-Cancer Agents in Medicinal Chemistry